BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16804922)

  • 1. Effect of the potassium channel opener WAY-133537 on the overactive bladder of spinalized rats.
    Elzayat E; Khaled S; Kashiwabara T; Elhilali M; Corcos J
    Neurourol Urodyn; 2006; 25(7):808-14. PubMed ID: 16804922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ZD6169 and ZD0947, 2 potassium adenosine triphosphate channel openers, on bladder function of spinalized rats.
    Abdel-Karim AM; Bialecki RA; Elhilali MM
    J Urol; 2002 Aug; 168(2):837-42. PubMed ID: 12131377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antiepileptic agent, levetiracetam, on urodynamic parameters and neurogenic bladder overactivity in chronically paraplegic rats.
    Elzayat EA; Campeau L; Karsenty G; Blok B; Padjen AL; Corcos J
    Urology; 2009 Apr; 73(4):922-7. PubMed ID: 19167033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the prostacyclin receptor antagonist RO3244019 in treating neurogenic detrusor overactivity after spinal cord injury in rats.
    Khera M; Boone TB; Salas N; Jett MF; Somogyi GT
    BJU Int; 2007 Feb; 99(2):442-6. PubMed ID: 17313428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of botulinum toxin on detrusor overactivity induced by intravesical adenosine triphosphate and capsaicin in a rat model.
    Atiemo H; Wynes J; Chuo J; Nipkow L; Sklar GN; Chai TC
    Urology; 2005 Mar; 65(3):622-6. PubMed ID: 15780404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of detrusor overactivity in rats with bladder outlet obstruction by a type 4 phosphodiesterase inhibitor.
    Nishiguchi J; Kwon DD; Kaiho Y; Chancellor MB; Kumon H; Snyder PB; Yoshimura N
    BJU Int; 2007 Mar; 99(3):680-6. PubMed ID: 17155980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the anticonvulsant medications pregabalin and lamotrigine on urodynamic parameters in an animal model of neurogenic detrusor overactivity.
    Loutochin O; Al Afraa T; Campeau L; Mahfouz W; Elzayat E; Corcos J
    Neurourol Urodyn; 2012 Sep; 31(7):1197-202. PubMed ID: 22473872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressions of voltage-gated K+ channel 2.1 and 2.2 in rat bladder with detrusor hyperreflexia.
    Gan XG; An RH; Bai YF; Zong DB
    Chin Med J (Engl); 2008 Aug; 121(16):1574-7. PubMed ID: 18982871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased urinary nerve growth factor as a predictor of persistent detrusor overactivity after bladder outlet obstruction relief in a rat model.
    Lee SR; Hong CH; Choi YD; Kim JH
    J Urol; 2010 Jun; 183(6):2440-4. PubMed ID: 20403616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat detrusor overactivity induced by chronic spinalization can be abolished by a transient receptor potential vanilloid 1 (TRPV1) antagonist.
    Santos-Silva A; Charrua A; Cruz CD; Gharat L; Avelino A; Cruz F
    Auton Neurosci; 2012 Jan; 166(1-2):35-8. PubMed ID: 22037502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the potassium channel openers, WAY-133537, ZD6169, and celikalim on isolated bladder tissue and In vivo bladder instability in rat.
    Wojdan A; Freeden C; Woods M; Oshiro G; Spinelli W; Colatsky TJ; Sheldon JH; Norton NW; Warga D; Antane MM; Antane SA; Butera JA; Argentieri TM
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1410-8. PubMed ID: 10336534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of M274773, a neurokinin-2 receptor antagonist, on bladder function in chronically spinalized rats.
    Abdel-Karim AM; Barthlow HG; Bialecki RA; Elhilali MM
    J Urol; 2005 Oct; 174(4 Pt 1):1488-92. PubMed ID: 16145477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction.
    Kaiho Y; Nishiguchi J; Kwon DD; Chancellor MB; Arai Y; Snyder PB; Yoshimura N
    BJU Int; 2008 Mar; 101(5):615-20. PubMed ID: 18070178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure.
    Yokoyama O; Miwa Y; Oyama N; Aoki Y; Ito H; Akino H
    J Urol; 2007 Nov; 178(5):2208-12. PubMed ID: 17870108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of potassium channel modulators on human detrusor smooth muscle myogenic phasic contractile activity: potential therapeutic targets for overactive bladder.
    Darblade B; Behr-Roussel D; Oger S; Hieble JP; Lebret T; Gorny D; Benoit G; Alexandre L; Giuliano F
    Urology; 2006 Aug; 68(2):442-8. PubMed ID: 16904481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central inhibitory effect of intravesically applied botulinum toxin A in chronic spinal cord injury.
    Munoz A; Somogyi GT; Boone TB; Smith CP
    Neurourol Urodyn; 2011 Sep; 30(7):1376-81. PubMed ID: 21509809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of tension-free vaginal tape on overactive bladder symptoms in women with stress urinary incontinence: significance of detrusor overactivity.
    Choe JH; Choo MS; Lee KS
    J Urol; 2008 Jan; 179(1):214-9. PubMed ID: 18001792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal effective dose of dysport and botox in a rat model of neurogenic detrusor overactivity.
    Behr-Roussel D; Oger S; Pignol B; Pham E; Le Maux A; Chabrier PE; Caisey S; Compagnie S; Picaut P; Bernabé J; Alexandre L; Giuliano F; Denys P
    Eur Urol; 2012 May; 61(5):1054-61. PubMed ID: 22341129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overactivity and structural changes in the chronically ischemic bladder.
    Azadzoi KM; Tarcan T; Kozlowski R; Krane RJ; Siroky MB
    J Urol; 1999 Nov; 162(5):1768-78. PubMed ID: 10524933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the ATP-sensitive potassium channel opener ZM226600 on cystometric parameters in rats with ligature-intact, partial urethral obstruction.
    Pinna C; Sanvito P; Bolego C; Cignarella A; Puglisi L
    Eur J Pharmacol; 2005 May; 516(1):71-7. PubMed ID: 15913601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.